BSF EnterpriseBSFAF Pretax Margin % is -1,330.23% as of Sep. 2025. The stock has 3 warning signs investors should review. Among 945 Biotechnology companies, BSF Enterprise ranks worse than 84.44% on this metric.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
BSF Enterprise Pretax Margin % Related Terms
BSF Enterprise Pretax Margin % Historical Data
* Premium members only.
The historical data trend for BSF Enterprise's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSFAF vs VRTX, REGN, ALNY: Pretax Margin % Comparison
For the Biotechnology subindustry, BSF Enterprise's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BSF Enterprise Pretax Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BSF Enterprise's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where BSF Enterprise's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSF Enterprise (BSFAF) has a Pretax Margin % of -1,330.23% as of Sep. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on BSF Enterprise and its competitors. According to the industry distribution chart, BSF Enterprise ranks #798 out of 945 companies in the Biotechnology industry, placing it in the top 84.4%.
Is BSF Enterprise's Pretax Margin % too high?
BSF Enterprise's current Pretax Margin % is -1,330.23%. Based on the distribution chart, BSF Enterprise ranks #798 out of 945 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does BSF Enterprise's Pretax Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BSF Enterprise ranks #798 out of 945 companies for Pretax Margin %. This places BSF Enterprise in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on BSF Enterprise and its competitors. BSF Enterprise's current Pretax Margin % is -1,330.23%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BSF Enterprise stock overvalued right now?
BSF Enterprise (BSFAF) has a current Pretax Margin % of -1,330.23%. The current Pretax Margin % is -1,330.23%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For BSF Enterprise (BSFAF), the current Pretax Margin % is -1,330.23% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BSF Enterprise PLC is a United Kingdom-based biotech company. The Company is focused on developing biotechnological solutions using cell-based tissue engineering to help generate cultured meat, lab-grown leather, as well as human corneas, collagen growth and skin substitutes. The Company operates through its wholly owned subsidiary, 3D Bio-Tissues Limited (3DBT), which is a clinical and cellular agriculture company engaged in producing human corneas that could help restore vision to millions of people.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSFAF has been successfully added to your 